For rare diseases, a case-control study is the most efficient and appropriate design. In a case-control study, individuals with the disease (cases) are identified, and then a comparable group without the disease (controls) is selected. The past exposure status of both groups is then compared to identify potential risk factors. A prospective cohort study would be impractical for a very rare disease because a very large number of individuals would need to be followed for a long time to observe a sufficient number of new cases. Cross-sectional studies measure exposure and outcome simultaneously and are not ideal for establishing temporality or studying rare diseases efficiently. Randomized controlled trials are experimental studies used to test the efficacy of interventions, not to identify risk factors for rare diseases.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.